We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
101
Hilton Worldwide
HLT
$74B
$33.8M 0.24%
232,199
-22,040
-9% -$3.14M
ILMN icon
102
Illumina
ILMN
$29.4B
$33.6M 0.24%
184,149
-16,247
-8% -$3.29M
BMY icon
103
Bristol-Myers Squibb
BMY
$127B
$33.2M 0.24%
519,856
-366,724
-41% -$24.6M
PYPL icon
104
PayPal
PYPL
$49.5B
$33.2M 0.24%
497,296
-283,176
-36% -$19.3M
OLED icon
105
Universal Display
OLED
$3.71B
$33.2M 0.24%
230,197
-16,851
-7% -$2.41M
SLB icon
106
SLB Ltd
SLB
$77.8B
$33.1M 0.24%
674,868
+520,396
+337% +$24.8M
SLAB icon
107
Silicon Laboratories
SLAB
$7.15B
$33.1M 0.24%
209,646
+17,736
+9% +$2.68M
VLO icon
108
Valero Energy
VLO
$89.8B
$32.6M 0.24%
277,633
+248,804
+863% +$28.9M
VIPS icon
109
Vipshop
VIPS
$6.84B
$32.5M 0.24%
1,971,840
+440,360
+29% +$6.9M
BCYC
110
Bicycle Therapeutics
BCYC
$270M
$32.5M 0.23%
1,273,261
-29,950
-2% -$696K
BNY
111
Bank of New York Mellon
BNY
$108B
$32.2M 0.23%
723,889
+527,395
+268% +$22.6M
KDNY
112
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$31.7M 0.23%
826,155
-100,000
-11% -$2.57M
MRTX
113
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$31.6M 0.23%
873,763
+109,498
+14% +$4.51M
COST icon
114
Costco
COST
$415B
$31.5M 0.23%
58,439
+18,278
+46% +$9.25M
URI icon
115
United Rentals
URI
$71.1B
$30.6M 0.22%
68,786
+4,960
+8% +$1.84M
GWW icon
116
W.W. Grainger
GWW
$65.3B
$30.6M 0.22%
38,773
-4,443
-10% -$3.06M
LULU icon
117
lululemon athletica
LULU
$13B
$30.5M 0.22%
80,614
-12,632
-14% -$4.66M
CRWD icon
118
CrowdStrike
CRWD
$187B
$30.1M 0.22%
820,924
-179,588
-18% -$6.26M
APLS
119
DELISTED
Apellis Pharmaceuticals
APLS
$29.7M 0.22%
326,507
-117,000
-26% -$10.1M
OC icon
120
Owens Corning
OC
$11.5B
$29.7M 0.21%
227,349
-216,419
-49% -$23.7M
UPS icon
121
United Parcel Service
UPS
$97.6B
$29.5M 0.21%
164,469
-40,490
-20% -$7.19M
OTIS icon
122
Otis Worldwide
OTIS
$27.4B
$29.5M 0.21%
331,168
-89,490
-21% -$7.54M
ABBV icon
123
AbbVie
ABBV
$458B
$29M 0.21%
215,185
+15,561
+8% +$2.28M
KROS icon
124
Keros Therapeutics
KROS
$199M
$29M 0.21%
721,061
-23,996
-3% -$1.05M
AZO icon
125
AutoZone
AZO
$48.3B
$28.6M 0.21%
11,462
-1,454
-11% -$3.71M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.